Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 11:2021:3006853.
doi: 10.1155/2021/3006853. eCollection 2021.

The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art

Affiliations
Review

The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art

Fatemeh Zahedipour et al. J Oncol. .

Abstract

Osteosarcoma is a major form of malignant bone tumor that typically occurs in young adults and children. The combination of aggressive surgical strategies and chemotherapy has led to improvements in survival time, although individuals with recurrent or metastatic conditions still have an extremely poor prognosis. This disappointing situation strongly indicates that testing novel, targeted therapeutic agents is imperative to prevent the progression of osteosarcoma and enhance patient survival time. Curcumin, a naturally occurring phenolic compound found in Curcuma longa, has been shown to have a wide variety of anti-tumor, anti-oxidant, and anti-inflammatory activities in many types of cancers including osteosarcoma. Curcumin is a highly pleiotropic molecule that can modulate intracellular signaling pathways to regulate cell proliferation, inflammation, and apoptosis. These signaling pathways include RANK/RANKL, Notch, Wnt/β-catenin, apoptosis, autophagy, JAK/STAT, and HIF-1 pathways. Additionally, curcumin can regulate the expression of various types of microRNAs that are involved in osteosarcoma. Therefore, curcumin may be a potential candidate for the prevention and treatment of osteosarcoma. This comprehensive review not only covers the use of curcumin in the treatment of osteosarcoma and its anti-cancer molecular mechanisms but also reveals the novel delivery strategies and combination therapies with the aim to improve the therapeutic effect of curcumin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
The role of curcumin in the regulation of the RANK/RANKL pathway in osteosarcoma.
Figure 2
Figure 2
The effect of curcumin on apoptosis and autophagy signaling pathways in osteosarcoma.

References

    1. Sadykova L. R., Ntekim A. I., Muyangwa-Semenova M., et al. Epidemiology and risk factors of osteosarcoma. Cancer Investigation . 2020;38(5):259–269. doi: 10.1080/07357907.2020.1768401. - DOI - PubMed
    1. Ritter J., Bielack S. S. Osteosarcoma. Annals of Oncology . 2010;21(Suppl 7):vii320–vii325. doi: 10.1093/annonc/mdq276. - DOI - PubMed
    1. Bishop M. W., Janeway K. A., Gorlick R. Future directions in the treatment of osteosarcoma. Current Opinion in Pediatrics . 2016;28(1):26–33. doi: 10.1097/mop.0000000000000298. - DOI - PMC - PubMed
    1. Benjamin R. S. Adjuvant and neoadjuvant chemotherapy for osteosarcoma: a historical perspective. Advances in Experimental Medicine and Biology . 2020;1257:1–10. doi: 10.1007/978-3-030-43032-0_1. - DOI - PubMed
    1. Marina N., Gebhardt M., Teot L., Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. The Oncologist . 2004;9(4):422–441. doi: 10.1634/theoncologist.9-4-422. - DOI - PubMed

LinkOut - more resources